Author

Nathan Grellier

Observed names: Grellier, Nathan, N Grellier, N. Grellier

Institutions: Inserm, Sorbonne Université, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Antoine, Fédération Hospitalo-Universitaire, Paris Center for Microbiome Medicine, Centre de Recherche Saint-Antoine

Observed institutions: Inserm, Université de Poitiers, Sorbonne Université, Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Antoine, Fédération Hospitalo-Universitaire, Paris Center for Microbiome Medicine, Centre Hospitalier Universitaire de Poitiers, Centre de Recherche Saint-Antoine, Université de Nantes, Nantes Université

ORCID: 0000-0002-0452-3218

Observed ORCID: 0000-0002-0452-3218

OpenAlex ID: A5021686525

Gossip in the gut: Quorum sensing, a new player in the host-microbiota interactions

2021 · Garance Coquant, Doriane Aguanno, et al. · World Journal of Gastroenterology · 47

PDF

Gut microbiota in inflammation and colorectal cancer: A potential Toolbox for Clinicians

2024 · Nathan Grellier, Andrea Severino, et al. · Best Practice & Research Clinical Gastroenterology · 26

Treatment of Antibiotic Refractory Chronic Pouchitis With JAK Inhibitors and S1P Receptor Modulators: An ECCO CONFER Multicentre Case Series

2023 · Davide Giuseppe Ribaldone, Giulia Testa, et al. · Journal of Crohn s and Colitis · 26

PDF

Impact of IBD-Associated Dysbiosis on Bacterial Quorum Sensing Mediated by Acyl-Homoserine Lactone in Human Gut Microbiota

2022 · Nathan Grellier, Marcelino T. Suzuki, et al. · International Journal of Molecular Sciences · 22

PDF

Early ileal resection in Crohn's disease is not associated with severe long‐term outcomes: The ERIC study

2024 · Nathan Grellier, Julien Kirchgesner, et al. · Alimentary Pharmacology & Therapeutics · 12

PDF

P735 JAK inhibitors and S1P receptor modulators for the treatment of antibiotic refractory chronic pouchitis: an ECCO CONFER Multicentre Case Series

2024 · G Testa, D G Ribaldone, et al. · Journal of Crohn s and Colitis · 2

PDF

Drug Interaction With Advanced Therapies in Inflammatory Bowel Diseases: A Blind Spot to Tackle

2025 · Nathan Grellier, Julien Kirchgesner · United European Gastroenterology Journal · 1

PDF

Boc.03.3: Treatment of Antibiotic Refractory Chronic Pouchitis With Jak Inhibitors and S1p Receptor Modulators: an Ecco Confer Multicentre Case Series

2024 · G. Testa, D.G. Ribaldone, et al. · Digestive and Liver Disease · 1

Gut dysbiosis in Crohn's disease: Never so close to solving the chicken-and-egg enigma: Commentary to “Gut microbiome composition is associated with future onset of Crohn's disease in healthy first-degree relatives, by Raygoza Garay JA et al., Gastroenterology 2023”

2023 · Nathan Grellier, Harry Sokol, et al. · Clinics and Research in Hepatology and Gastroenterology · 1

Modifying the course and altering the natural history of Crohn’s disease

2026 · Beatriz Gros, Lauranne A. A. P. Derikx, et al. · Expert Review of Clinical Pharmacology

Malattia di Crohn

2026 · N. Grellier, P. Seksik · EMC - AKOS - Trattato di Medicina

Acceptability of probiotics, fecal microbiota transplantation, and emerging microbiome-derived therapies in patients with inflammatory bowel diseases: A cross-sectional Survey Study

2026 · Nathan Grellier, Clotilde Policar, et al. · Therapeutic Advances in Gastroenterology

Enfermedad de Crohn

2026 · N. Grellier, P. Seksik · EMC - Tratado de Medicina

Safety of advanced therapies during pregnancy in women with immune-mediated inflammatory diseases: a systematic review and meta-analysis

2026 · Ophelie Pingeon, Nathan Grellier, et al. · Journal of Crohn s and Colitis

Maladie de Crohn

2026 · N. Grellier, P. Seksik · EMC - Traité de médecine AKOS

P1134 Persistent Perineal Suppurations After Abdominoperineal Resection in IBD: A Multicentre Cohort Study

2026 · N Grellier, P Mclellan, et al. · Journal of Crohn s and Colitis

PDF

P0856 Acceptability of Probiotics, Fecal Microbiota Transplantation, and Emerging Microbiome-Derived Therapies in IBD: A Cross-Sectional Survey Study

2026 · N Grellier, C Policar, et al. · Journal of Crohn s and Colitis

Letter: Early Ileal Resection in Crohn's Disease Is Not Associated With Severe Long‐Term Outcomes: The ERIC Study: Authors' Reply

2025 · Nathan Grellier, Julien Kirchgesner, et al. · Alimentary Pharmacology & Therapeutics

PDF

P0294 Functional outcomes after primary ileocecal resection for Crohn’s disease

2025 · N Grellier, J Kirchgesner, et al. · Journal of Crohn s and Colitis

PDF

The role of digestive microbiota in human health, discoveries and prospects in 2024

2024 · Paul McLellan, Nathan Grellier, et al. · Hépato-Gastro & Oncologie Digestive

Editorial: Re‐Evaluating Early Surgery in Ileocaecal Crohn's Disease. Author's Reply

2024 · Nathan Grellier, Julien Kirchgesner, et al. · Alimentary Pharmacology & Therapeutics

PDF

Inflammatory bowel diseases and eosinophilic oesophagitis: Two overlapping disorders?

2023 · Nathan Grellier, Julien Kirchgesner · United European Gastroenterology Journal

DOP50 Impact of Inflammatory Bowel Disease associated dysbiosis on bacterial quorum sensing mediated by Acyl-homoserine Lactone in human gut microbiota

2023 · N Grellier, M Suzuki, et al. · Journal of Crohn s and Colitis

PDF

DOP10 Early intestinal resection in Crohn’s Disease is not associated with severe long-term disease course

2023 · N Grellier, J Kirchgesner, et al. · Journal of Crohn s and Colitis

PDF

Works count: 26

Citation count: 138

H-index: 5

I10-index: 5